Blood groups and susceptibility to virus infection: new developments

Area of Science:

• Immunology
• Virology
• Glycobiology

Background:

• Histo-blood group antigens, particularly P1PK and GLOB system antigens, are implicated in bacterial infections.
• Emerging evidence suggests a role for specific glycosphingolipids in HIV infection.
• The P/Gb3 histo-blood group antigen's role in HIV-1 infection warrants further investigation.

Purpose of the Study:

• To explore the role of the P/Gb3 histo-blood group antigen in HIV-1 infection.
• To understand the protective mechanisms conferred by P/Gb3 against HIV-1.
• To evaluate the potential of P/Gb3 and its analogues as therapeutic agents.

Main Methods:

• Review of early studies on glycosphingolipid interactions with HIV envelope glycoprotein 120.
• Analysis of recent findings on cellular and soluble P/Gb3 antigen's effect on HIV-1 infection.
• Examination of the correlation between P/Gb3 expression and HIV susceptibility.

Main Results:

• Cellular or soluble P/Gb3 antigen confers protection against HIV-1 infection.
• This protection is mediated by inhibiting the fusion of the HIV-1 envelope to target cell membranes.
• P/Gb3 expression shows an inverse correlation with HIV-1 susceptibility for both X4 and R5 tropic strains.

Conclusions:

• P/Gb3 is the first identified natural resistance factor against HIV infection expressed on the cell surface.
• Increased P/Gb3 expression correlates with decreased HIV infection risk.
• Soluble P/Gb3 analogues inhibit HIV through direct viral inhibition and blocking viral entry, suggesting therapeutic potential.